caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1699968503

Shanmuga Pudunagar SubbiahMD

Hematology-OncologyUpland, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,427
Unique beneficiaries
—
Total services
5,557
Distinct HCPCS
10
Medicare payment
$446K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — above median (cohort median 4,173).
REFERRAL NETWORK

Where Shanmuga Pudunagar Subbiah's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 16 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Michael Gentry
Diagnostic Radiology · Colton, CA
51221
Chandler Shyu
Diagnostic Radiology · Colton, CA
48207
Patricia Ash
Nurse Practitioner · Duarte, CA
40180
Peter Malek
Diagnostic Radiology · Los Angeles, CA
39123
Chul Chae
Diagnostic Radiology · Colton, CA
39138
Tung Huynh
Diagnostic Radiology · Colton, CA
30108
Ha Le
Diagnostic Radiology · Colton, CA
25104
John Sohn
Diagnostic Radiology · Colton, CA
2485
Munther Alqaisi
Radiation Oncology · San Bernardino, CA
24422
Farabi Hussain
General Surgery · Colton, CA
21249
DANG, THUAN1755
Kris Storkersen
Ophthalmology · Colton, CA
15120
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
850
Beneficiaries
—
Total drug cost
$2.8M
Distinct drugs
36
Brand share
38.2%
Top prescribed drugs
Apixaban74 claims
Tamoxifen Citrate74 claims
Gabapentin49 claims
Osimertinib Mesylate44 claims
Anastrozole43 claims
QUALITY · MIPS · 2024
Final MIPS score
82.3
Quality
52.9
Cost
70.8
Improvement activities
40.0
Promoting interop.
93.0
Payment adjustment
0.31%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$10K
Payment records
81
By payment type
Consulting Fee$7K
Food and Beverage$1K
Long term medical supply or device loan$1K
Education$232